Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862895 | 0.93 | MAPT (0.32) | TSHRMAPT | |
| SCHEMBL19862890 | 0.92 | KDM4E (0.34) | TSHRMAPT | |
| SCHEMBL19862900 | 0.91 | KDM4E (0.33) | TSHRMAPT | |
| SCHEMBL18594323 | 0.90 | KDM4E (0.32) | — | |
| SCHEMBL19862872 | 0.90 | ALOX5 (0.33) | — | |
| SCHEMBL19863005 | 0.90 | KDM4E (0.32) | TSHRMAPT | |
| SCHEMBL18594108 | 0.89 | KDM4E (0.35) | TSHR | |
| SCHEMBL19862880 | 0.89 | KDM4E (0.35) | TSHR | |
| SCHEMBL19863038 | 0.89 | KDM4E (0.35) | TSHRMAPT | |
| SCHEMBL18594077 | 0.89 | MAPT (0.34) | TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10230056-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2019-03-12 | — | — | US | disclosed |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-15 | — | — | US | disclosed |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10230056-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, NR2E3 | TSHR 3741/4885MAPT 746/4885 |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, NR2E3 | TSHR 3741/4885MAPT 746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.